Characteristics, Cardiac Involvement, and Outcomes of Multisystem Inflammatory Syndrome of Childhood Associated with severe acute respiratory syndrome coronavirus 2 Infection.
Adolescent
Anti-Inflammatory Agents
/ therapeutic use
Betacoronavirus
COVID-19
Child
Child, Preschool
Coronary Aneurysm
Coronavirus Infections
/ complications
Female
Fever
Humans
Inflammation
Male
Mucocutaneous Lymph Node Syndrome
/ diagnosis
New York City
Pandemics
Pneumonia, Viral
/ complications
Retrospective Studies
SARS-CoV-2
Shock
/ complications
Systemic Inflammatory Response Syndrome
/ diagnosis
Treatment Outcome
Ventricular Dysfunction, Left
/ complications
COVID-19 Drug Treatment
adolescents
coronary aneurysm
inflammation
kawasaki disease
Journal
The Journal of pediatrics
ISSN: 1097-6833
Titre abrégé: J Pediatr
Pays: United States
ID NLM: 0375410
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
02
06
2020
revised:
09
06
2020
accepted:
10
06
2020
pubmed:
20
6
2020
medline:
12
9
2020
entrez:
20
6
2020
Statut:
ppublish
Résumé
We report on the presentation and course of 33 children with multisystem inflammatory syndrome in children and confirmed severe acute respiratory syndrome coronavirus 2 infection. Hemodynamic instability and cardiac dysfunction were prominent findings, with most patients exhibiting rapid resolution following anti-inflammatory therapy.
Identifiants
pubmed: 32553873
pii: S0022-3476(20)30746-0
doi: 10.1016/j.jpeds.2020.06.044
pmc: PMC7293762
pii:
doi:
Substances chimiques
Anti-Inflammatory Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
141-145Subventions
Organisme : NLM NIH HHS
ID : R01 LM012836
Pays : United States
Organisme : NIA NIH HHS
ID : R24 AG064191
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.